Who Paid My Doc
GLORIA AF Registry Phase II III Core
Research payments
$981,836
Through program year 2021, $981,836 in research payments was reported against GLORIA AF Registry Phase II III Core, across 258 payments, paid by Boehringer Ingelheim Pharmaceuticals, Inc..
- Paid by
- Boehringer Ingelheim Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $4,096 | 1 |
| 2020 | Research | $226,282 | 97 |
| 2019 | Research | $751,458 | 160 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Minang Turakhia Palo Alto, CA Named on 3 payments
- Steven Forman Los Alamitos, CA Named on 2 payments
- Stanley Koch Morton, IL Named on 2 payments
- Charles Augenbraun Norwalk, CT Named on 2 payments
- Elizabeth Kaufman Cleveland, OH Named on 2 payments
- Amir Malik Fort Worth, TX Named on 2 payments
- Abraham Salacata Alpena, MI Named on 2 payments
- Venkatesh Nadar Camp Hill, PA Named on 2 payments
- Nashwa Gabra Burke, VA Named on 2 payments
- Rudolph Evonich Lanse, MI Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.